Jaejin An to Treatment Outcome
This is a "connection" page, showing publications Jaejin An has written about Treatment Outcome.
Connection Strength
0.725
-
Blood Pressure Reduction and Changes in Antihypertensive Medication Use Among Patients With Hypertension Who Initiated Sodium-Glucose Cotransporter-2 Inhibitors. J Clin Hypertens (Greenwich). 2024 Nov; 26(11):1318-1321.
Score: 0.185
-
Effectiveness and safety of Dabigatran 110 mg versus 150 mg for Stroke Prevention in Patients with Atrial Fibrillation at High Bleeding Risk. Clin Ther. 2023 07; 45(7):e151-e158.
Score: 0.169
-
Cardiovascular and kidney outcomes of spironolactone or eplerenone in combination with ACEI/ARBs in patients with diabetic kidney disease. Pharmacotherapy. 2021 12; 41(12):998-1008.
Score: 0.151
-
Stroke and Bleeding Risk Associated With Antithrombotic Therapy for Patients With Nonvalvular Atrial Fibrillation in Clinical Practice. J Am Heart Assoc. 2015 Jul 17; 4(7).
Score: 0.098
-
Multiple medication adherence and its effect on clinical outcomes among patients with comorbid type 2 diabetes and hypertension. Med Care. 2013 Oct; 51(10):879-87.
Score: 0.086
-
Comparison of Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Bioprosthetic Heart Valves. Am J Cardiol. 2021 05 01; 146:22-28.
Score: 0.036